|
Report Date : |
08.10.2013 |
IDENTIFICATION DETAILS
|
Name : |
LA QUIMICA FARMACEUTICA S.A. |
|
|
|
|
Registered Office : |
Avda.Primer Presidente 1736 y calle Yrendague, Asuncion |
|
|
|
|
Country : |
Paraguay |
|
|
|
|
Year of Establishments: |
1943 |
|
|
|
|
Legal Form : |
Public Limited Company |
|
|
|
|
Line of Business : |
Development and marketing
of drug for use human. |
|
|
|
|
No. of Employees : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Paraguay |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
PAraguay ECONOMIC OVERVIEW
Landlocked Paraguay has a market
economy distinguished by a large informal sector, featuring re-export of imported
consumer goods to neighboring countries, as well as the activities of thousands
of microenterprises and urban street vendors. A large percentage of the
population, especially in rural areas, derives its living from agricultural
activity, often on a subsistence basis. Because of the importance of the
informal sector, accurate economic measures are difficult to obtain. On a per
capita basis, real income has stagnated at 1980 levels. The economy grew
rapidly between 2003 and 2008 as growing world demand for commodities combined
with high prices and favorable weather to support Paraguay's commodity-based
export expansion. Paraguay is the sixth largest soy producer in the world.
Drought hit in 2008, reducing agricultural exports and slowing the economy even
before the onset of the global recession. The economy fell 3.8% in 2009, as
lower world demand and commodity prices caused exports to contract. The
government reacted by introducing fiscal and monetary stimulus packages. Growth
resumed at a 13% level in 2010, the highest in South America, but slowed to
about 4% in 2011 as the stimulus subsided. In 2012, severe drought and
outbreaks of foot-and-mouth disease led to a drop in beef and other
agricultural exports and the economy contracted about 0.5%. Political
uncertainty, corruption, limited progress on structural reform, and deficient
infrastructure are the main obstacles to long-term growth.
|
Source : CIA |
LA QUIMICA
FARMACEUTICA S.A.
"QUIMFA"
RUC. 800024230
BEGINNER OF ACTIVITIES. INCORPORATED IN
1943. NOT PROVIDED BALANCE SHEET. NO NEGATIVE. FIT FOR OPERATIONS OF MODERATE
IMPORTANCE WITH ADEQUATE GUARANTEES.
DEVELOPMENT AND MARKETING DRUG FOR USE HUMAN.
LEGAL FORM: PUBLIC LIMITED COMPANY
CREATED: 1943
REGISTERED RPC: 1943
DURATION: UNLIMITED
END OF FISCAL YEAR: 31.12
Legal and dependences operatives address:
Avda.Primer Presidente 1736 y calle Yrendague, Asuncion, Republic of Paraguay.
Phone. 595.21 222391
Fax. 595.21 224791
E.Mail: quimfa@quimfa.com.py
lorenzobritel@quimfa.com.py
Website: www.quimfa.com.py
OSCAR LUIS RAMIREZ (Commercial Manager).
OSCAR LUIS RAMIREZ:
-------------------
Is Doctor Bioquimico, graduated from the Faculty of Medical Sciences and before
joining the company holding served as Marketing Manager in the social reason
LABORATORIOS ETICOS S.A. and Manager in HOECHST MARION ROUSSE PARAGUAY.
It has been determined through the inquiries
that have been made, that the activities in question were initiated and
implemented by this society, which governs their actions by legal clauses
mentioned above.
It is a pharmaceutical company for the category with 70 years in the domestic
market, being located in the city of Asuncion in the Republic of Paraguay.
It has an installed manufacturing plant in Trinidad, Asuncion, Paraguay, which
is dedicated to the preparation of solid pharmaceutical products, injections,
oral liquid forms of syrups, drops, suspensions and semosolidos in forms of
creams, ointments, gels with active general non-beta-lactams.
The infrastructure and implemented quality system allows you to export
medicines to several countries of Latin America.
At company premises our agent was attended by Mr. LORENZO BRITES,
administrative department official, not is provided any kind of finance
information.
REAL ESTATE:
------------
Avda.Primer Presidente 1736 y calle Yrendague, Asuncion, Republic of Paraguay.
Surface of 20.000 m2 and covered surface of 10.000 m2.
The society is devoted to the activities
mentioned above, with appropriate operational structure, in which many
employees play in the care of different tasks, under the direct supervision of
their primary responsibility.
The products are developed under international standards so as to ensure the
strictest vigilance over the quality and safety of the same.
Among the products it produces,
markets and exports may be mentioned the following:
- A 3 COMPUESTO
- A 3 COMPUESTO N.F.
- AAS 100
- AAS 125
- AAS 325
- AAS 500
- AAS 81
- ACIDO FOLICO 10 MG NOVOPHAR
- ACIDO FOLICO 30 MG NOVOPHAR
- ACIDO FOLICO 05 MG NOVOPHAR
- AEROFAGIL 200
- AEROFAGIL AMPOLLAS BEBIBLES
- AEROFAGIL EMULSION
- AEROFAGIL GOTAS
- AFOLIC 10 MG
- AFOLIC 01 MG
- AFOLIC 05 MG
- AFONITOL CHERRY
- AFONITOL EUCALIPTO
- AFONITOL MENTOLADO
HSBC BANK
BANCO CONTINENTAL
BBVA PARAGUAY
Centralhouse.
INSURANCE:
----------
MAPFRE S.A.
Recent investigations have determined that
it is canceling the obligations assumed in terms classified as normal and is
well referenced.
* NOT OBJECTIONS.
It concludes that operations could relate to
this society credit within sums of moderate importance in practical conditions.
At higher levels of consideration, it is advisable to seek appropriate
guarantees.
* SUITABLE FOR CREDITS.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.78 |
|
UK Pound |
1 |
Rs.99.06 |
|
Euro |
1 |
Rs.83.84 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to
overcome financial difficulties seems comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.